Endoglin (CD105) is not a specific selection marker for endothelial cells in human islets of Langerhans

被引：0
|
作者：
C. P. D. Wheeler-Jones
C. E. Clarkin
C. E. Farrar
P. Dhadda
P. Chagastelles
N. Nardi
P. M. Jones
机构：
[1] The Royal Veterinary College,Comparative Biomedical Sciences
[2] University of Southampton,Centre for Biological Sciences
[3] Kings College London,Diabetes Research Group, Division of Diabetes and Nutritional Sciences, School of Medicine
[4] Universidade Federal do Rio Grande do Sul,undefined
[5] Universidade Luterana do Brasil,undefined
来源：
Diabetologia | 2013年 / 56卷
关键词：
CD 105; Endoglin; Human islet; Mesenchymal stromal cells; Microvascular endothelial cells;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：222 / 224
页数：2
相关论文
共 50 条
  • [31] Expression of endoglin (CD105) in cervical cancer
    Zijlmans, H. J.
    Fleuren, G. J.
    Hazelbag, S.
    Sier, C. F.
    Dreef, E. J.
    Kenter, G. G.
    Gorter, A.
    BRITISH JOURNAL OF CANCER, 2009, 100 (10) : 1617 - 1626
  • [32] Expression of endoglin (CD105) in cervical cancer
    H J Zijlmans
    G J Fleuren
    S Hazelbag
    C F Sier
    E J Dreef
    G G Kenter
    A Gorter
    British Journal of Cancer, 2009, 100 : 1617 - 1626
  • [33] Endoglin (CD105) expression in sinonasal polyposis
    Ottaviano, Giancarlo
    Cappellesso, Rocco
    Mylonakis, Ioannis
    Lionello, Marco
    Favaretto, Niccolo
    Giacomelli, Luciano
    Spoladore, Cristiano
    Marchese-Ragona, Rosario
    Marino, Filippo
    Staffieri, Alberto
    Martini, Alessandro
    Marioni, Gino
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2015, 272 (11) : 3367 - 3373
  • [34] Recombinant Cells as a Tool for Evaluating the Specific Activity of Radiolabeled Antibodies against Endoglin (CD105)
    Shashkova, O. A.
    Smirnov, I. V.
    Pinevich, A. A.
    Avrov, K. O.
    Terekhina, L. A.
    Malakhov, I. S.
    Stolbovaya, A. Yu.
    Gryazeva, I. V.
    Vartanyan, N. L.
    Krutetskaya, I. Yu.
    Antuganov, D. O.
    Shatik, S. V.
    Samoilovich, M. P.
    APPLIED BIOCHEMISTRY AND MICROBIOLOGY, 2023, 59 (07) : 1018 - 1026
  • [35] Recombinant Cells as a Tool for Evaluating the Specific Activity of Radiolabeled Antibodies against Endoglin (CD105)
    O. A. Shashkova
    I. V. Smirnov
    A. A. Pinevich
    K. O. Avrov
    L. A. Terekhina
    I. S. Malakhov
    A. Yu. Stolbovaya
    I. V. Gryazeva
    N. L. Vartanyan
    I. Yu. Krutetskaya
    D. O. Antuganov
    S. V. Shatik
    M. P. Samoilovich
    Applied Biochemistry and Microbiology, 2023, 59 : 1018 - 1026
  • [36] Targeting of immunoliposomes to endothelial cells using a single-chain Fv fragment directed against human endoglin (CD105)
    Völkel, T
    Hölig, P
    Merdan, T
    Müller, R
    Kontermann, RE
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2004, 1663 (1-2): : 158 - 166
  • [37] CD105 (endoglin) as risk marker in AML patients undergoing stem cell transplantation
    Melanie Märklin
    Ilona Hagelstein
    Clemens Hinterleitner
    Helmut R. Salih
    Joseph Kauer
    Jonas S. Heitmann
    International Journal of Hematology, 2020, 112 : 57 - 64
  • [38] Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer
    Wikström, P
    Lissbrandt, IF
    Stattin, P
    Egevad, L
    Bergh, A
    PROSTATE, 2002, 51 (04): : 268 - 275
  • [39] Synergy between anti-endoglin (CD105) monoclonal antibodies and TGF-β in suppression of growth of human endothelial cells
    She, XW
    Matsuno, F
    Harada, N
    Tsai, H
    Seon, BK
    INTERNATIONAL JOURNAL OF CANCER, 2004, 108 (02) : 251 - 257
  • [40] CD105 (endoglin) as risk marker in AML patients undergoing stem cell transplantation
    Maerklin, Melanie
    Hagelstein, Ilona
    Hinterleitner, Clemens
    Salih, Helmut R.
    Kauer, Joseph
    Heitmann, Jonas S.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 112 (01) : 57 - 64
12345